Fundz

Neuro Pace Inc reported raising $69.4 Million in an initial SEC Form D filing, from an offering of $96.4 Million

PUBLIC · NPCEAug 31, 2020$69.4M of $96.4M raised

Amount Raised

$69.4 Million

$69.4 Million sold, per SEC Form D (first sale Aug 31, 2020)

Round Type

Venture

Mountain ViewHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as NeuroPace that raised within 45 days of this round, from Fundz verified event records.

  • Expanesthetics, Inc raised $240K (Seed) on October 15, 2020.
  • Reperio Health raised $2.8M (Seed) on October 15, 2020.
  • ZipRad, Inc. raised $240K (Seed) on October 15, 2020.
  • Expanesthetics, Inc raised $110K (Seed) on October 15, 2020.
  • Squid Ink, Inc. raised $30M on October 15, 2020.
  • Medable Inc. raised $10M on October 14, 2020.

Who to call at NeuroPace, and when

A new round usually means NeuroPace is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NeuroPace raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeuroPace, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NeuroPace. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NeuroPace

Location

455 N. BERNARDO AVENUE

Mountain View, California, United States

About

Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeuroPace raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contacts20 people are listed at NeuroPace. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NeuroPace's next move

See what Strategic adds

NeuroPace raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.